Skip to content

Perspective Therapeutics CATX Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

CytomX Therapeutics logo
CytomX TherapeuticsCTMX
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
Immunome logo
ImmunomeIMNM
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
uniQure logo
uniQureQURE
Precigen logo
PrecigenPGEN

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's operating lease right-of-use assets in other assets?
Perspective Therapeutics (CATX) reported operating lease right-of-use assets in other assets of $2.44M in Q1 2026.
How has Perspective Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
Perspective Therapeutics's operating lease right-of-use assets in other assets increased by 22.6% year-over-year, from $1.99M to $2.44M.
What is the long-term trend for Perspective Therapeutics's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Perspective Therapeutics's operating lease right-of-use assets in other assets has grown at a 11.0% compound annual growth rate (CAGR), from $891K to $1.5M.